Latest Observability News

Eden Innovations’ US subsidiary has secured its first EdenCrete®Pz7 order from Holcim Mexico, marking the product’s expansion to three countries within the Holcim Group’s concrete operations.

Blue Star Helium has successfully drilled the Jackson 2 well to total depth at its Galactica project in Colorado, confirming strong natural gas flow and advancing the project toward commercial production.

Kip McGrath Education Centres announces the departure of long-serving CEO Storm McGrath, with Chair Damian Banks stepping in as Executive Chair during the leadership transition.

Pact Group Holdings has received conditional approval from the ASX for its voluntary delisting, pending shareholder endorsement at an upcoming extraordinary general meeting scheduled for 12 June 2025.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.

Stellar Resources reports strong high-grade tin intercepts at Queen Hill, underpinning potential resource upgrades and advancing the Heemskirk Tin Project towards development.

Enlitic has formalised a binding MOU with GE HealthCare to deliver multi-million-dollar migration services, contingent on raising A$10 million through a new capital placement. This partnership and funding round mark a pivotal step in Enlitic’s growth strategy within AI-driven medical imaging.

Next Science Limited has successfully had a derivative complaint dismissed in Florida, while continuing legal action against former employees for breach of post-employment restraints.

Patagonia Lithium Ltd reports exceptional Nuclear Magnetic Resonance (NMR) porosity and specific yield results from well JAM24-04 at its Formentera Lithium Brine Project in Argentina, revealing porosity values more than double previous estimates and promising lithium concentrations that bolster project viability.

Immutep’s combination of eftilagimod alfa (efti) and KEYTRUDA® delivers a striking 17.6-month median overall survival in head and neck cancer patients with low PD-L1 expression, a group with limited treatment options.

Kingsgate Consolidated Limited has announced an on-market share buy-back as part of its capital management strategy, signaling confidence amid current market conditions.